Ernst Heinen

Shares of Aratana Therapeutics Inc (NASDAQ: PETX), a pet therapeutics company that commercializes bio-pharmaceutical products for companion animals, were trading higher by more than 25 percent early Tuesday morning before returning some of the gains. Aratana Therapeutics announced after Monday...

Shares of Aratana Therapeutics Inc (NASDAQ: PETX) were surging higher by more than 17 percent Monday after the company announced positive results from its pivotal field effectiveness study of capromorelin (AT-002), the company's innovative therapeutic for appetite stimulation in dogs. Aratana...